Pregnancy increases women’s risk of blood clotting disorders, blood clots block arteries and blood vessels, diminishing or altogether preventing blood flow to essential organs When blood flow is interrupted in the placenta, the baby is starved of the nutrients and oxygen it needs for healthy development.
Risks of Clotting Disorders
- Intrauterine Growth Restriction (IUGR).
- Severe pre-eclampsia.
- Miscarriage after 10 weeks.
- Placental abruption (the placenta separates from the uterine lining too soon).
Types of Clotting Disorders:
- Thrombophilia is hereditary and most common types are:
- Prothrombin G20210A mutation
- Factor V Leiden mutation
- Antithrombin III (abbreviated as “AT III”) deficiency
- Methylenetetrahydrofolate reductase C677 (“MTHFR”) mutation
- Protein S deficiency
- Protein C deficiency
Treatment of blood clotting disorders in pregnancy:
- Blood thinners, throughout the pregnancy and up to 8 weeks after delivery.
- Anti-coagulants, like unfractionated heparin and low-molecular-weight heparin
- Aspi-med ( Baby Aspirin)
- These choices are safe during pregnancy for mother and baby and may continue for 8-12 weeks post delivery with short discontinuation during labor.